|
Volumn 28, Issue 4, 1996, Pages 2051-2053
|
An anti-CD2 monoclonal antibody that elicits alloantigen-specific hyporesponsiveness
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BTI 322;
CD2 ANTIGEN;
LEU 5B;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD 2;
MT 910;
OKT 11;
OKT 3;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIGEN EXPRESSION;
ANTIGEN SPECIFICITY;
CONFERENCE PAPER;
CONTROLLED STUDY;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
IMMUNOBIOLOGY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
MIXED LYMPHOCYTE REACTION;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
ANTIGENS, CD2;
CYTOKINES;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIGENS;
KILLER CELLS, NATURAL;
MICE;
MOLECULAR SEQUENCE DATA;
RATS;
T-LYMPHOCYTES;
|
EID: 0029833743
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (0)
|